Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neutralizing Antibody Titers 6 Years after Third Dose of Inactivated Japanese Encephalitis Vaccine
2013-004366-34Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE), sponsored by Medical University of Vienna. Primary endpoint: Geometric Mean Titer of JEV neutralizing antibodies. Started Nov 2013; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2013-004366-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004366-34.